Navigation Links
Nexavar Data to Be Presented at American Society of Clinical Oncology Annual Meeting
Date:5/18/2011

WAYNE, N.J. and SOUTH SAN FRANCISCO, May 18, 2011 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that data evaluating the use of Nexavar® (sorafenib) tablets will be presented in a scientific forum at the 2011 Annual Meeting of the American Society of Clinical Oncology (ASCO), June 3-7, in Chicago.  

"Bayer and Onyx remain committed to researching the potential utility of sorafenib, and the number of abstracts being presented at this year's ASCO is a true testament to this commitment," said Dr. Dimitris Voliotis, Vice President, Global Clinical Development Oncology, Bayer HealthCare. "The companies look forward to continuing to work together, and with various institutions and study groups, to further explore sorafenib.  Sorafenib has demonstrated efficacy in patients with unresectable liver cancer and advanced kidney cancer, and we remain committed to determine the potential of this therapy for patients."

Bayer and Onyx-sponsored, Phase 2 and 3 studies, and other research evaluating sorafenib, including investigational uses, being presented at ASCO include:

Efficacy and safety of intra-patient dose escalation of sorafenib as first-line treatment for metastatic renal cell carcinoma (mRCC)

  • Professor Martin Gore, Medical Director, The Royal Marsden and Professor of Cancer Medicine at The Institute of Cancer Research, United Kingdom
  • Abstract number: 4609
  • June 5, 8:00 am – 12:00 pm, General Poster Session

Sorafenib plus chemotherapy for patients with advanced breast cancer previously treated with bevacizumab.

  • Clifford Hudis, M.D., Memorial Sloan-Kettering Cancer Center
  • Abstract number: 1009
  • June 6, 11:45 am, Oral Abstract Session<
    '/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Bayer HealthCare Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
2. Vicus Therapeutics Announces Initiation of Phase 2 Trial to Evaluate VT-122 in Patients with Liver Cancer Receiving Nexavar
3. Bayer and Onyx Announce Nexavar Data Presentations at 35th European Society for Medical Oncology Congress
4. Phase 3 Trial of Nexavar in First-Line Advanced Non-Small Cell Lung Cancer Does Not Meet Primary Endpoint of Overall Survival
5. Nexavar in Combination With Chemotherapy Demonstrates Activity in Patients With Advanced Breast Cancer in Two Phase 2 Studies
6. Bayer and Onyx Announce Nexavar Data Presentations at 60th American Association for the Study of Liver Diseases Annual Meeting
7. Phase 3 Trial of Nexavar in Chemotherapy-Naive Patients with Advanced Melanoma Does Not Meet Primary Endpoint
8. Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
9. The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer
10. New Nexavar Data Presented in Multiple Tumor Types at 44th American Society of Clinical Oncology Annual Meeting
11. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 2014 /PRNewswire-iReach/ -- "Australia Capsule Endoscopy Systems Market Outlook ... Capsule Endoscopy Systems market. The report provides value, in ... prices (in US dollars) within market segments: ... Capsule Endoscopes , Capsule Endoscopy Data Recorders ... also provides company shares and distribution shares data for ...
(Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, ... TCGRx, of Powers Lake, Wisconsin ... in a distribution and co-marketing agreement allowing ScriptPro ... pharmacies throughout the United States ... pharmacy management and workflow systems to retail and ...
(Date:7/25/2014)... , July 25, 2014 GrowBLOX Sciences, Inc. (OTCQB: ... Memorandum of Understanding ("MOU") with LaurelCo, LLC, an ... acquisition of both cultivation and dispensary medical marijuana licenses in ... the MOU, GBLX will acquire a 20% equity interest in ... GrowBLOX TM growing chambers, as well as all technology ...
Breaking Medicine Technology:Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3
... YORK, Feb. 28, 2012  On February 28th, 2012, the ... for those interested in speaking at its 2012 Digital ... New York City,s Pier Sixty. At ... in New York City—over 600 healthcare providers, healthcare technology ...
... Feb. 28, 2012   Alexander Orthopaedic Associates (AOA) in ... in their practice with White Plume Technologies between ... Systems, (ADSC) practice management system (PM system). ... gaps in the billing process unfilled. White Plume Technologies ...
Cached Medicine Technology:Call for Speakers: New York's Digital Health Conference 2012 2Alexander Orthopaedic Associates Chooses White Plume Technologies to Fill the EMR Gap 2
(Date:7/26/2014)... Earlier this week, the big announcement that fans of music was ... iHeartRadio Music Festival on Sept. 19 and 20 from the ... of music will have an act they are excited to see ... of Taylor Swift, as well as Zac Brown Band and Eric ... Grande, and Iggy Azalea, while R&B fans will be excited to ...
(Date:7/26/2014)... gas chromatography reagents report defines and segments the concerned market ... chromatography reagents market in Europe is valued at $ 314.8 ... $445.5 million by 2018, at a CAGR of 8.6 %, ... the European gas chromatography reagents market, to get an idea ... glimpse of the segmentation of gas chromatography reagents market in ...
(Date:7/26/2014)... 26, 2014 As reported by ... changing based on 3 factors: smaller spaces, multi-generational access, ... bathroom trend of 2014 lists, including this article ... Amerec , a leading manufacturer of steam bath ... largely due to smaller spaces and an effort to ...
(Date:7/26/2014)... New York, New York (PRWEB) July 26, 2014 ... continue to be filed in U.S. courts, Bernstein ... calling on federal health regulators to ban uterine morcellation. ... individuals include a 46-year-old mother of four from California ... of uterine cancer called leiomyosarcoma just 10 days after ...
(Date:7/26/2014)... July 26, 2014 We’ve all ... the playing field; however, concussions in the workplace ... occupations with the highest risk of head injury ...     Firefighters ,     Police officers ,     Race ...     Delivery personnel , “Most ...
Breaking Medicine News(10 mins):Health News:iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival for Sept. 19 & 20th 2Health News:iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival for Sept. 19 & 20th 3Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Gas Chromatography Reagents Market is Expected to Reach $445.5 million in 2018 - New Report by MicroMarket Monitor 5Health News:Amerec Finds Bathroom Design Trends Change Based on Water Consumption and Other Factors 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 4Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 2Health News:KORT Physical Therapists Take the Mystery Out of Identifying and Treating Workplace Head Injuries 3
... targeted searches to ob/gyn specialty-specific ... patient care and practice management, ... (http://www.OBGManagement.com ), a leader in the field of obstetrics ... latest search engine tool: OBGfindit.com (http://www.OBGfindit.com )., ...
... discovered a new perspective in the study of infectious ... looking at an organism and how it works within ... published in Environmental Microbiology, Dr Carla Pruzzo, Dr Luigi ... bacteria and its interaction with the environment and found ...
... Sharp Rise in Gonorrhea Cases, HARRISBURG, Pa., May 2 ... of Gonorrhea last year in Delaware County,the Pennsylvania Department of ... and 24 be routinely screened for the,disease, as well as ... to 921 in 2007 from 513,the year before., Of ...
... (Nasdaq:,WBMD) and HLTH Corporation (Nasdaq: HLTH ) today ... the Third Annual Needham & Company,Internet & Digital Media ... ET., Investors, analysts and the general public are ... presentation over the Internet. The broadcast,can be accessed at ...
... Lupus Foundation of,America joins a coalition of approximately 100 ... May 10. More than 1.5 million,Americans and at least ... struggle daily with the often-debilitating health,consequences of the chronic ... an unbalanced immune system that can become,destructive to any ...
... DIEGO, May 2 /PRNewswire-USNewswire/ - It is the cosmetic ... from their hips and thighs and,redistributing it to their ... or effective. Fat grafting for breast enhancement will be,discussed ... American Society,for Aesthetic Plastic Surgery (ASAPS) being held at ...
Cached Medicine News:Health News:OBGManagement.com and Convera(R) Launch Search Site for Physicians in the ObGyn Specialty 2Health News:Lupus Organizations Issue International Call-to-Action to Combat Disease Affecting Five Million People 2Health News:Breast Enhancement With Fat: Pros and Cons 2Health News:Breast Enhancement With Fat: Pros and Cons 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: